Proceedings ArticleDOI
Use Of Angiotensin Converting Enzyme Inhibitors Or Angiotensin Receptor Blockers And Clinical Outcomes Among Patients At-risk For Acute Lung Injury
Timothy R. Watkins,Luciano B. Lemos-Filho,Ousama Dabbagh,Steven Y. Chang,Pauline K. Park,Michelle N. Gong +5 more
Reads0
Chats0
About:
This article is published in American Thoracic Society International Conference.The article was published on 2011-05-01. It has received 6 citations till now. The article focuses on the topics: Angiotensin II receptor type 1 & Angiotensin-converting enzyme.read more
Citations
More filters
Journal ArticleDOI
Fifty Years of Research in ARDS. Is Acute Respiratory Distress Syndrome a Preventable Disease
TL;DR: In this review, the rationale, current evidence, and future directions in ARDS prevention are summarized.
Journal ArticleDOI
Clinical review: Early treatment of acute lung injury - paradigm shift toward prevention and treatment prior to respiratory failure
TL;DR: Current strategies that target prevention of ALI and some of the most promising pharmacologic agents for early treatment ofALI prior to the onset of respiratory failure that requires mechanical ventilation are discussed.
Journal ArticleDOI
Acute Respiratory Distress Syndrome: Etiology, Pathogenesis, and Summary on Management:
Shawn K Kaku,Christopher D. Nguyen,Natalie N Htet,Dominic Tutera,Juliana Barr,Juliana Barr,Harman S Paintal,Harman S Paintal,Ware G. Kuschner,Ware G. Kuschner +9 more
TL;DR: The acute respiratory distress syndrome has multiple causes and is characterized by acute lung inflammation and increased pulmonary vascular permeability, leading to hypoxemic respiratory failure and bilateral pulmonary radiographic opacities.
Journal ArticleDOI
Emerging therapies for the prevention of acute respiratory distress syndrome.
Carl Ruthman,Emir Festic +1 more
TL;DR: It is postulate that overall morbidity and mortality rates from ARDS in the future will be contingent upon decreasing the overall incidence of ARDS through effective identification of those at risk and early application of proven supportive care and pharmacological interventions.
Journal ArticleDOI
Acute Respiratory Distress Syndrome: Bench-to-Bedside Approaches to Improve Drug Development
Musaddique Hussain,Chengyun Xu,Mashaal Ahmad,Abdul Majeed,Meiping Lu,Xiling Wu,Lanfang Tang,Ximei Wu +7 more
TL;DR: To improve drug development for ARDS, researchers need to deeply analyze the “omics” approaches, reevaluate the suitable therapeutic targets, resolve the problems of inadequate animal modeling, develop the strategies to reduce the heterogeneity, and reconsider new therapeutic and analytical approaches for better designs of clinical trials.